Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Avenio tram commences passenger service in The Hague

03.11.2015

For Dutch tram operator HTM, today marks the start of passenger services with brand new Siemens trams in The Hague, Netherlands. The first Avenio will run on line 2, which connects the western suburb of Kraayenstein with Leidschendam in the northeast via The Hague's main station. The Siemens trams will also gradually progress to operating on lines 1, 9, 15 and 17, with test runs already being conducted on the next route earmarked for Avenio, line 11. HTM has ordered a total of 60 Avenio trams from Siemens.

"Before commencing passenger services, we carried out extensive tests, as we make no compromise when it comes to safety. I am very satisfied with the results, and very proud of our employees for their hard work and dedication. I would like to thank the metropolitan region of Rotterdam The Hague (MRDH) and all the local authorities involved for making this step forward possible.

I would also like to take the opportunity to express my appreciation to the manufacturer, Siemens, for having achieved these results. Siemens has built the trams according to our requirements and wishes – and it is now time for our passengers to take over," says Jaap Bierman, CEO of HTM.

"The Hague is the second city to operate passenger services with our trams. The test runs have already shown that the Avenio is well-equipped for this city's tram network, which is in service more than 150 years. By virtue of its exceptionally smooth and quiet operating profile, it is ultimately passengers who will benefit the most from the Avenio," adds Sandra Gott-Karlbauer, CEO of Urban Transport at Siemens.

The Hague is carrying out extensive structural work along the lines to enable operation of the new low-floor trams, with tracks being renewed and all stops to receive new, specially adapted tram platforms. More than half of the tracks and stops have already been converted to accommodate the new trams.

For further information on Mobility Division, please see www.siemens.com/mobility


Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry.

The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 343,000 employees worldwide on a continuing basis.

Further information is available on the Internet at www.siemens.com


Reference Number: PR2015110059MOEN


Contact
Ms. Ellen Schramke
Mobility Division
Siemens AG

Nonnendammallee 101

13629 Berlin

Germany

Tel: +49 (30) 386-22370

ellen.schramke​@siemens.com

Ellen Schramke | Siemens Mobility

More articles from Transportation and Logistics:

nachricht German-British Research project for even more climate protection in the rail industry
28.05.2020 | Technische Universität Dresden

nachricht Delivery drones instead of postal vans?
22.04.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Transportation and Logistics >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Restoring vision by gene therapy

Latest scientific findings give hope for people with incurable retinal degeneration

Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major...

Im Focus: Small Protein, Big Impact

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

New image of a cancer-related enzyme in action helps explain gene regulation

05.06.2020 | Life Sciences

Silicon 'neurons' may add a new dimension to computer processors

05.06.2020 | Physics and Astronomy

Protecting the Neuronal Architecture

05.06.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>